Where is Myka Labs located?

Myka Labs is headquartered in San Francisco, United States.

How many employees does Myka Labs have?

As of Aug 31, 2026, the latest employee count at Myka Labs is 3.

Where does Myka Labs rank among its competitors?

Myka Labs ranks 10th amongst 16 active competitors, of which 4 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was VieCure, which secured $43M in Jan, 2026.

Who are the top competitors of Myka Labs?

Myka Labs' top competitors include VieCure, Syapse and BostonGene. Among them, VieCure secured the most recent funding round in January, 2026.

Myka Labs - 2026 Company Profile, Funding & Competitors

Company Details

Provider of an AI-based integrated solutions for interventional oncology. The platform combines advanced artificial intelligence along with proprietary sensorized catheter designs and intraluminal ultrasound hardware, known as "Conflux" that enables less invasive procedures, streamlined procedural workflows, and reduced ionizing radiation exposure for care teams.

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Funding Raised

Investors

Mission BioCapital

Ranked

10^th among 16 active competitors

Employee Count

3 as on Aug 31, 2026

Similar Companies

VieCure & 20 more

View Myka Labs' full profile

Myka Labs is a funded company. Myka Labs has 1 institutional investor.

View details of Myka Labs's funding rounds and investors

Myka Labs' employee count trend

Myka Labs has 3 employees as of Aug 26. Here is Myka Labs's employee count trend over the years:

Uncover Myka Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Myka Labs include VieCure, Syapse and BostonGene. Here is the list of Top 10 competitors of Myka Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	VieCure 2015, Greenwood Village (United States), Series C	AI-based platform for generating oncology treatment plans	$113M	Northpond Ventures, Durable Capital Partners ... & 2 others	58/100
2nd	Syapse 2008, San Francisco (United States), Acquired	Developer of precision medicine for the treatment of cancer	$223M	Amgen Business Development, Innovatus Capital Partners ... & 14 others	55/100
3rd	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	54/100
4th	Oncospace 2018, Baltimore (United States), Acquired	Provider of healthcare solutions focused on cancer patients	$900K	America’s Seed Fund, NIH	38/100
5th	OncoRx Insights 2022, Boulder (United States), Unfunded	Provider of radical new insights and solutions for oncologists and patients in the healthcare industry	-	-	28/100
6th	Melatech 2018, Copenhagen (Denmark), Seed	AI-based patient treatment management tool for providers	$574K	Accelerace & 2 others	28/100
7th	PersonaDx 2022, Chicago (United States), Unfunded	Provider of a platform for diagnosis and treatment of cancer through blood-based biomarker tests	-	-	25/100
8th	Curenetics London (United Kingdom), Unfunded	Cloud and AI-based cancer care planning platform for professionals	-	-	24/100
9th	Iakan Health 2019, Valencia (Spain), Funding Raised	Provider of an AI-based decision support platform for personalized cancer treatment	-	Lanzadera	23/100
10th	Myka Labs 2021, San Francisco (United States), Funding Raised	Provider of an AI-based integrated solutions for interventional oncology	-	Mission BioCapital	23/100